Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A condition or physical state produced by the ingestion, injection, inhalation of or exposure to a deleterious agent.
Biomarker and diagnostic research for poisoning has been reported in the published literature.
1 FDA-approved treatment is available for poisoning, including ATROPINE INJECTION, 2 MG (N/A, approved 2018).
Brand Name | Generic Name | Mechanism | Approved | Market Status |
|---|---|---|---|---|
34 clinical trials registered, 10 recruiting. Interventions under study include other interventions, drug therapy, procedural interventions, and medical devices. Pipeline includes 2 PHASE4, 1 PHASE3, 3 PHASE2. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06885411](https://clinicaltrials.gov/study/NCT06885411) |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 6:00 AM UTC
ATROPINE INJECTION, 2 MG |
— |
2018 |
Available |
Gene therapy approaches for poisoning have been reported in the published literature.
34 trials found
Ototoxicity in Patients With MoM Hip Bearings |
— |
Reinier Haga Orthopedisch Centrum |
RECRUITING |
[NCT07459166](https://clinicaltrials.gov/study/NCT07459166) | A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade | PHASE2 | Clear Scientific, Inc. | RECRUITING |
[NCT07456592](https://clinicaltrials.gov/study/NCT07456592) | Development of an Aptamer-based Lateral Flow Device for Point-of-care Detection of Toxic Chinese Medicine Herbs (ALPTH Project) | — | The University of Hong Kong | RECRUITING |
[NCT07103356](https://clinicaltrials.gov/study/NCT07103356) | Table-Top Water Pitcher to Reduce Arsenic Exposure Among Well Users in New Hampshire | NA | Trustees of Dartmouth College | RECRUITING |
[NCT05471479](https://clinicaltrials.gov/study/NCT05471479) | Activated CHARcoal in Poisoned Patient - Pilot Trial | PHASE4 | Laval University | RECRUITING |
500 publications have been identified in PubMed for poisoning. Kisho has analyzed 175 by research type. Research spans Epidemiology / Natural History (38%), Review / Meta-Analysis (26%), and Case Report / Case Series (23%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 67 | 38% |
Research summaries | 46 | 26% |
Patient case studies | 40 | 23% |
Clinical study results | 6 | 3% |
Laboratory research | 6 | 3% |
Other research | 4 | 2% |
Testing and diagnosis research | 3 | 2% |
New treatment approaches | 3 | 2% |
Eizadi-Mood N (2026). [PMID: 42102663](https://pubmed.ncbi.nlm.nih.gov/42102663/). *J Forensic Leg Med*. [Epidemiology / Natural History]
Nguyen HN (2026). [PMID: 29262048](https://pubmed.ncbi.nlm.nih.gov/29262048/). *Unknown Journal*. [Review / Meta-Analysis]
Conrad SW (2026). [PMID: 41642795](https://pubmed.ncbi.nlm.nih.gov/41642795/). *The American journal of drug and alcohol abuse*. [Epidemiology / Natural History]
Muraki I (2026). [PMID: 41958626](https://pubmed.ncbi.nlm.nih.gov/41958626/). *JMA J*. [Review / Meta-Analysis]
Ferner RE (2026). [PMID: 42003020](https://pubmed.ncbi.nlm.nih.gov/42003020/). *J R Soc Med*. [Review / Meta-Analysis]
Hayakawa K (2026). [PMID: 42088830](https://pubmed.ncbi.nlm.nih.gov/42088830/). *Toxicol Rep*. [Diagnostic / Biomarker]
Hahn PD (2026). [PMID: 41401830](https://pubmed.ncbi.nlm.nih.gov/41401830/). *Hosp Pediatr*. [Epidemiology / Natural History]
Lashin HI (2026). [PMID: 41831064](https://pubmed.ncbi.nlm.nih.gov/41831064/). *Cardiovascular toxicology*. [Clinical Trial Publication]
Shi X (2026). [PMID: 41337694](https://pubmed.ncbi.nlm.nih.gov/41337694/). *Reviews on environmental health*. [Epidemiology / Natural History]
Koppen A (2026). [PMID: 41182883](https://pubmed.ncbi.nlm.nih.gov/41182883/). *Ther Drug Monit*. [Review / Meta-Analysis]